Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCINE.L Regulatory News (CINE)

  • There is currently no data for CINE

Trading Statement

3 Dec 2019 07:00

RNS Number : 4178V
Cineworld Group plc
03 December 2019
 

FOR IMMEDIATE RELEASE

3 December 2019

CINEWORLD GROUP PLC

LONDON, 3 December 2019 - Cineworld Group plc ("the Group") announces its trading update for the period 1 January 2019 to 1 December 2019.

·; Integration benefits from Regal greater than anticipated, with estimated run-rate synergies increased from $150m to $190m

·; Successful launch of Unlimited program in the US in July 2019 generating positive impact on cash flow and box office performance

·; US refurbishment program progressing well with 20 new sites to be completed in the next 12 months

·; Given weaker box office, partially offset by strong execution of synergies and revenue initiatives, trading for the full year is expected to be slightly below management's expectations

 Pro-forma(1) revenue movements for the period were as follows:

 

Actual ($)

 

Constant Currency(2) ($)

 

Group(1)

US(1)

UK & Ireland

ROW(3)

 

Group(1)

US(1)

UK & Ireland

ROW(3)

Total revenue

(9.7%)

(10.9%)

(9.7%)

(0.5%)

 

(8.5%)

(10.9%)

(4.9%)

4.9%

Box Office

(12.8%)

(13.9%)

(12.7%)

(4.2%)

 

(11.6%)

(13.9%)

(8.1%)

1.2%

Retail

(7.4%)

(8.3%)

(8.7%)

2.0%

 

(6.3%)

(8.3%)

(3.9%)

7.7%

Other Income

2.2%

(0.4%)

7.4%

9.9%

 

3.6%

(0.4%)

13.1%

14.8%

 

(1) Pro-forma results reflect the Group and US performance had Regal been consolidated for the entirety of the period from 1 January 2018. For the purposes of percentage movements, the same comparative period has been applied.

(2) Constant currency movements have been calculated by applying the 2019 average exchange rates to the 2018 performance.

(3) ROW is defined as Rest of the World and includes Poland, Romania, Hungary, Czech Republic, Bulgaria, Slovakia and Israel.

 

Update on US Integration and Transformation Plan

Our integration plans for Regal have progressed well and management is pleased to announce an increase in achievable synergies from $150m to $190m following significant improvements in contractual terms and the elimination of excess costs. Further, the Group has achieved better than anticipated results from revenue initiatives. The full impact of all these additional initiatives and cost savings will be realised in 2020.

Our Unlimited program, which has successfully operated in the UK and Poland for several years, was launched in the US in July 2019. The program has been extremely well received and is well on track to reach membership levels above initial management expectations by year end. The program has assisted in mitigating the impact of the first-half closure of 16 loss making sites (168 screens) and other part-closed screens during renovation.

Our refurbishment program in the US is on track with 10 sites under refurbishment. Another 70 agreements have been signed for other strategic sites to be refurbished in the US in the near term. We expect these sites to result in a strong return on investment in line with our experience in the UK and ROW. An agreement has also been entered into with Lavazza, the Italian coffee chain, to incorporate coffee bars in new and refurbished sites, the first of which will open this month in Union Square, NY.

Investment in the latest technology continues to be a key pillar of the Group's strategy. During the second half of the year, the Group opened 15 ScreenX and 10 4DX across the estate. Both formats are proving very popular and we anticipate having around 40 4DXs and 30 ScreenX by end of 2019 and plan to double the amount in 2020.

During the second half of the year, as part of the Group's estate management strategy, five new sites (45 screens) were opened, two in the UK, two in the US and one in Poland. We have also continued to close unprofitable sites with five of the Group's sites closed in the second half, three in the US, one in the UK and one in Czech Republic. This brings the total number of sites in the Group as at 1 December 2019 to 786 with 9,498 screens. We also expect to open three new sites before the year-end (two in the UK and one in Hungary).

Box Office

As anticipated, the box office performance for the reported period was slower than the comparative period in 2018 reflecting the phasing of major releases and postponement of some highly anticipated movies to 2020. The second half of the year started strongly with the release of "The Lion King", "Spider-Man: Far from Home", the record-breaking "Joker" and recently "Frozen 2". There are still two major blockbusters to be released in 2019 with "Jumanji: The Next Level" and "Star Wars: The Rise of Skywalker" in December.

 

Outlook

Despite a challenging comparative period, Group performance has been resilient across the portfolio. We remain focused on operational performance, cash flow generation and de-leveraging which will be achieved within our current capital allocation framework with no change to the dividend policy.

 

The impact of the major releases in December is expected to continue the recent positive box office trend. However given the weaker full year box office, partially offset by strong execution of synergies and revenue initiatives, management expects trading for the full year to be slightly below management's expectations

Mooky Greidinger, Chief Executive Officer of Cineworld Group plc, commented:

"Despite the challenging backdrop, Cineworld has continued to execute well and our strategy of focusing on optimising customer experience remains unchanged. There is an impressive selection of movies to come, which coupled with our extensive premium technology-led offering and exciting food and beverage offerings, will contribute strongly to our operating results and underpin our mission to be "the best place to watch a movie". I am confident both about the future of the theatrical business as a whole and most importantly our ability to be a leader in it."

 

Appointment of Corporate Broker

With immediate effect, Goldman Sachs International has been appointed as a joint corporate broker alongside the Group's existing advisers.

 

 

 

 

Cautionary note concerning forward looking statements

Certain statements in this announcement are forward looking and so involve risk and uncertainty because they relate to events, and depend upon circumstances that will occur in the future and therefore results and developments can differ materially from those anticipated. The forward looking statements reflect knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

Contacts

Cineworld Group plc:

 

Finsbury:

 

Israel Greidinger

+44 (0) 20 8987 5000

James Leviton

+44 (0)20 7251 3801

Nisan Cohen

investors@cineworld.co.uk
Andy Parnis
cineworld-lon@finsbury.com

 

Manuela Van Dessel

 

 

Charlotte Cobb

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGBDDIGGBGCX
Date   Source Headline
2nd Jan 201910:47 amRNSTotal Voting Rights
24th Dec 201811:22 amRNSTR-1: Standard Form of Notification
21st Dec 201810:57 amRNSTR-1: Standard Form of Notification
7th Dec 20182:38 pmRNSDirector/PDMR Shareholding
4th Dec 201811:32 amRNSTR-1: Standard Form of Notification
4th Dec 201811:25 amRNSTR-1: Standard Form of Notification
3rd Dec 20181:24 pmRNSTotal Voting Rights
29th Nov 20184:12 pmRNSTR-1: Standard Form of Notification
28th Nov 201812:09 pmRNSTR-1: Standard Form of Notification
27th Nov 20184:04 pmRNSTR-1: Standard Form of Notification
15th Nov 20187:00 amRNSTrading Update
9th Nov 20184:09 pmRNSBlock Listing Six Monthly Return
5th Nov 201811:10 amRNSTR-1: Standard Form of Notification
1st Nov 201811:45 amRNSTotal Voting Rights
1st Oct 201810:52 amRNSTotal Voting Rights
21st Sep 20185:08 pmRNSInterim Dividend - Exchange Rate
3rd Sep 20181:21 pmRNSTotal Voting Rights
15th Aug 20184:15 pmRNSTR-1: Standard Form of Notification
9th Aug 20187:00 amRNSHalf-year Report
6th Aug 20181:15 pmRNSTR-1: Standard Form of Notification
1st Aug 20183:42 pmRNSTotal Voting Rights
20th Jul 201810:35 amRNSDirectorate Change
10th Jul 201811:53 amRNSTR-1: Standard Form of Notification
5th Jul 201812:07 pmRNSDirector Declaration
2nd Jul 201810:51 amRNSTotal Voting Rights
29th Jun 20184:26 pmRNSTR-1: Standard Form of Notification
26th Jun 20183:25 pmRNSTR-1: Standard Form of Notification
26th Jun 20183:12 pmRNSDirector/PDMR Shareholding
14th Jun 20183:11 pmRNSTR-1: Standard Form of Notification
12th Jun 201811:25 amRNSTR-1: Standard Form of Notification
11th Jun 201810:34 amRNSTR-1: Standard Form of Notification
8th Jun 201811:29 amRNSTR-1: Standard Form of Notification
7th Jun 20184:19 pmRNSDirector Declaration
5th Jun 20182:42 pmRNSTR-1: Standard Form of Notification
1st Jun 201812:44 pmRNSTotal Voting Rights
23rd May 20189:51 amRNSAdditional Listing
16th May 20182:22 pmRNSResults of Annual General Meeting
16th May 20187:00 amRNSTrading Statement
14th May 20186:05 pmRNSDirector/PDMR Shareholding
11th May 20187:00 amRNSChange in Presentation Currency
8th May 201810:38 amRNSAdditional Listing
1st May 201811:21 amRNSTotal Voting Rights
24th Apr 20184:10 pmRNSDirector/PDMR Shareholding
17th Apr 20186:13 pmRNSTR-1: Standard Form of Notification
13th Apr 20185:28 pmRNSTR-1: Standard Form of Notification
11th Apr 20185:07 pmRNSAnnual Report and Notice of Annual General Meeting
19th Mar 20184:09 pmRNSPDMR/Director Shareholding
15th Mar 20187:00 amRNSPreliminary Results
1st Mar 20184:34 pmRNSTotal Voting Rights
1st Mar 20188:07 amRNSRe-admission of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.